Paychex, Inc. (PAYX) - Q3 2025 10-Q Summary
Business Context and Reporting Period
This filing covers the quarterly period ended February 28, 2025 (Q3 of Fiscal 2025) and the nine months ended February 28, 2025. Paychex, Inc. is a leading human capital management (HCM) company providing technology and advisory services in HR, employee benefits, insurance, and payroll processing for small- to medium-sized businesses. The company operates as a single segment.
Key Financial Metrics
| Metric | Q3 2025 (3 Months) | Q3 2024 (3 Months) | 9 Months 2025 | 9 Months 2024 |
|---|---|---|---|---|
| Total Revenue | $1,509.0 million | $1,439.3 million | $4,144.4 million | $3,983.2 million |
| Operating Income | $691.8 million | $649.8 million | $1,776.6 million | $1,692.3 million |
| Net Income | $519.3 million | $498.6 million | $1,360.1 million | $1,310.5 million |
| Diluted EPS | $1.43 | $1.38 | $3.76 | $3.62 |
| Operating Margin | 45.8% | 45.1% | 42.9% | 42.5% |
| Cash from Operations (9mo) | $1,557.1 million | |||
| Long-Term Debt | $799.0 million (net of issuance costs) | |||
| Cash & Equivalents | $1,563.8 million (Corporate) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue increased 5% in Q3 and 4% year-to-date (YTD). Excluding the expiration of the Employee Retention Tax Credit (ERTC) program, revenue growth was 6% for both periods.
- Management Solutions: Up 5% in Q3 and 3% YTD, driven by client growth and price realization.
- PEO and Insurance Solutions: Up 6% in Q3 and 7% YTD, driven by growth in average worksite employees and insurance revenues.
- Expenses: Total expenses rose 4% in Q3 and 3% YTD. This includes $16.7 million in acquisition-related costs for the pending Paycor acquisition. PEO direct insurance costs increased 7% (Q3) and 14% (YTD) due to business growth.
- Interest Income: Interest on funds held for clients decreased 2% in Q3 due to lower average interest rates but increased 8% YTD due to higher average balances and rates.
- Other Income/Expense: Turned to a net expense of $6.0 million in Q3 (vs. $9.4 million income prior year) primarily due to $13.2 million in costs related to the Paycor acquisition financing (amortization of debt issuance costs and swaption contracts).
Guidance, Outlook, and Risks
- Paycor Acquisition: On January 7, 2025, Paychex agreed to acquire Paycor HCM, Inc. for $22.50 per share (approx. $4.1 billion enterprise value). The deal is expected to close in April 2025.
- Financing includes a $3.5 billion bridge loan commitment and $3.0 billion in interest rate swaption contracts to hedge against rate fluctuations.
- Capital Allocation: The company paid $353.0 million in dividends in Q3 ($0.98 per share). It repurchased 0.8 million shares YTD for $104.5 million. $296.0 million remains available under the current share repurchase program.
- Investment Portfolio: The company holds $3.4 billion in Available-for-Sale (AFS) securities with net unrealized losses of $67.9 million as of Feb 28, 2025. Management states these losses are due to interest rate changes, not credit risk, and intends to hold securities to maturity.
- Risks: Key risks include integration of the Paycor acquisition, cyberattacks, changes in government regulations (tax/HR), and macroeconomic factors affecting small business clients.
Investor Verification Checklist
- Paycor Closing Conditions: Verify the status of the Hart-Scott-Rodino waiting period and other customary closing conditions for the April 2025 target date.
- Financing Execution: Confirm the transition from the $3.5 billion bridge loan to permanent long-term fixed financing prior to the acquisition closing.
- Investment Portfolio Valuation: Monitor the $67.9 million in unrealized losses on AFS securities to ensure they remain non-credit related and do not require impairment charges if interest rates shift further.
- PEO Insurance Reserves: Review the adequacy of PEO workers' compensation and health insurance reserves, as these are subject to actuarial estimation and claim volatility.
- ERTC Impact: Assess the long-term revenue trajectory now that the ERTC program has fully expired, ensuring organic growth rates remain robust.